13 results · 23ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

LIQUICHEK ANTI-SM CONTROL, POSITIVE, CATALOG #115

FDA 510(k)
FDA Class 2 ·Immunology

RPI SKIN OR AIR TEMPERATURE PROBE

FDA 510(k)
FDA Class 2 ·General Hospital

SMARTWIRE/SMARTMAP PRESSURE SYSTEM

FDA 510(k)
FDA Class 2 ·Cardiovascular

POWERED WHEELCHAIR

FDA Adverse Event
Malfunction ·INVACARE TAYLOR STREET·Product code ITI·March 27, 2013

HEARTMATE II LVAS

FDA Adverse Event
Injury ·THORATEC CORPORATION·Product code DSQ·March 18, 2011

AED

FDA Adverse Event
Malfunction ·WELCH ALLYN PROTOCOL, INC.·Product code MKJ·March 27, 2008

AIMING ARM/ RADIOLUCENT

FDA Adverse Event
Malfunction ·SYNTHES GMBH·Product code JDS·January 29, 2025

AIM-ARM RADIOLUC

FDA Adverse Event
Malfunction ·WRIGHTS LANE SYNTHES USA PRODUCTS LLC·Product code JDS·March 30, 2022

AIMING ARM/ RADIOLUCENT

FDA Adverse Event
Malfunction ·SYNTHES GMBH·Product code JDS·December 29, 2022

AIMING ARM/ RADIOLUCENT

FDA Adverse Event
Malfunction ·SYNTHES GMBH·Product code HWC·September 19, 2022

AIMING ARM/ RADIOLUCENT

FDA Adverse Event
Malfunction ·WRIGHTS LANE SYNTHES USA PRODUCTS LLC·Product code JDS·January 12, 2022

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

CADD-Solis VIP ambulatory Infusion Pumps, Model 2110. Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024